Brief: Transgene, PersonGen Partner On Therapy Against Solid Tumors

Transgene SA

18/01/2022 16:50

Jan 18 (Reuters) - TRANSGENE SA  TRNG.PA :
    * TRANSGENE AND PERSONGEN ANNOUNCE COLLABORATION TO EVALUATE
A NEW
COMBINATION THERAPY AGAINST SOLID TUMORS
    * COLLABORATION TO EVALUATE COMBINATION OF TRANSGENE'S
ONCOLYTIC
VIRUS AND PERSONGEN'S CAR-T CELLS IN PRECLINICAL MODELS
    * WILL DEVELOP MULTIPLE NEW OV CANDIDATES, USING ITS
PATENTED
ONCOLYTIC VIRUS BACKBONE VVCOPTK-RR- AND ITS INVIR.IO™
TECHNOLOGY PLATFORM
    * COLLABORATION AIMS TO DEMONSTRATE COMBINATION'S LIKELY
SYNERGISTIC MECHANISMS TO POTENTIATE CAR-T CELL THERAPY

Source text for Eikon:  ID:nBwbSm9c9a 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))